AGER and tuberculosis: The strengths of this study include its prospective, case-control design; active TB, latent TB, and the uninfected were compared; events occurring along the proposed signaling pathway (inflammasome–HMGB1/RAGE–cytokines) were investigated at multiple levels (plasma, cell surface, gene expression) to provide a more comprehensive picture.